Director's Insider Purchase: Social media discussions have spotlighted a director's $100,000 share acquisition at Accuray, noted as their first-ever buy. This development arrives amid a 60% stock decline over six months. Many view the move as a vote of confidence from leadership.
Early Positioning Signals: Traders on social media are positioning ARAY as an under-the-radar opportunity, likening it to past runners that gained significantly pre-hype. Chatter emphasizes buying before crowds arrive. Volume remains low, underscoring nascent interest.
Additional Insider Activity: Another insider reportedly purchased thousands of shares recently. Such filings have fueled speculation on potential turnaround. Sentiment leans toward optimism despite market pressures.
Note: This discussion summary was generated from an AI condensation of post data.
Accuray Insider Trading Activity
Accuray insiders have traded $ARAY stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ARAY stock by insiders over the last 6 months:
- STEVEN F MAYER has made 3 purchases buying 250,000 shares for an estimated $134,675 and 0 sales.
- NEVE STEPHEN R. LA (CEO) purchased 20,000 shares for an estimated $19,410
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Accuray Revenue
Accuray had revenues of $102.2M in Q2 2026. This is a decrease of -11.99% from the same period in the prior year.
You can track ARAY financials on Quiver Quantitative's ARAY stock page.
Accuray Hedge Fund Activity
We have seen 53 institutional investors add shares of Accuray stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TCW GROUP INC added 3,558,595 shares (+29.9%) to their portfolio in Q4 2025, for an estimated $2,934,417
- ACUITAS INVESTMENTS, LLC removed 2,392,126 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,972,547
- HEARTLAND ADVISORS INC removed 1,668,193 shares (-33.4%) from their portfolio in Q4 2025, for an estimated $1,375,591
- HARBERT FUND ADVISORS, INC. removed 1,448,820 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,419,529
- ARMISTICE CAPITAL, LLC added 1,176,000 shares (+35.4%) to their portfolio in Q4 2025, for an estimated $969,729
- PARKMAN HEALTHCARE PARTNERS LLC added 852,012 shares (+inf%) to their portfolio in Q4 2025, for an estimated $702,569
- MACKENZIE FINANCIAL CORP added 831,220 shares (+76.5%) to their portfolio in Q4 2025, for an estimated $685,424
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Accuray Government Contracts
We have seen $5,738,639 of award payments to $ARAY over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MODALITY: RT LINAC STATION: VAMC TAMPA, FL PURCHASE ORDER: 36A79725N0093, 673B40032, 673B40036 REQUIREMEN...: $4,053,103
- ACCURAY CYBERKNIFE MAINTENANCE: $376,500
- EMERGENCY 6 MONTHS PM&R ACCURAYTOMOTHERAPY RADIXACT SYSTEM: $351,181
- RADIXACT X7 TOMOTHERAPY SYSTEM PMI: $336,255
- SERVICE CONTRACT FOR ACCURAY CYBERKNIFE: $326,600
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Accuray Analyst Ratings
Wall Street analysts have issued reports on $ARAY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/05/2026
To track analyst ratings and price targets for Accuray, check out Quiver Quantitative's $ARAY forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
